Literature DB >> 31070041

Molecular and clinical patterns of local progression in the pancreatic remnant following resection of pancreatic intraductal papillary mucinous neoplasm (IPMN).

Elisabetta Sereni1, Claudio Luchini2, Roberto Salvia1, Antonio Pea3.   

Abstract

Intraductal papillary mucinous neoplasms (IPMN) are pancreatic cystic lesions that can progress to invasive carcinoma. Consensus guidelines indicate surgery for IPMN at high risk of malignant progression, as assessed by specific radiological and clinical criteria, whereas an active radiological surveillance is recommended for IPMN at low risk of malignancy. The management of IPMN is further complicated by the risk of developing a distinct new cyst or a ductal adenocarcinoma in the remnant pancreas, either synchronously or metachronously. Several studies therefore investigated local progression in the remnant pancreas following partial pancreatic resection for IPMN and whether an unstable epithelium at risk for malignant degeneration may exist. Understanding the biological mechanisms behind progression of IPMN will help in identifying patients that would benefit from the resection of the entire pancreas.

Entities:  

Keywords:  Local progression; ; resected intraductal papillary mucinous neoplasm (resected IPMN)

Mesh:

Year:  2019        PMID: 31070041     DOI: 10.21037/cco.2019.04.03

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  2 in total

1.  Nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study.

Authors:  Jia-Yuan Wu; Yu-Feng Wang; Huan Ma; Sha-Sha Li; Hui-Lai Miao
Journal:  World J Gastroenterol       Date:  2020-02-07       Impact factor: 5.742

Review 2.  Malignant epithelial/exocrine tumors of the pancreas.

Authors:  Claudio Luchini; Federica Grillo; Matteo Fassan; Alessandro Vanoli; Paola Capelli; Gaetano Paolino; Giuseppe Ingravallo; Giuseppina Renzulli; Claudio Doglioni; Alessandro D'Amuri; Paola Mattiolo; Sara Pecori; Paola Parente; Ada M Florena; Giuseppe Zamboni; Aldo Scarpa
Journal:  Pathologica       Date:  2020-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.